カテゴリ： 世界, 医療/バイオ, Market Monitor Global

炎症性眼疾患治療のグローバル市場展望 2023年-2029年：ドライアイ疾患、非感染性前ブドウ膜炎、アレルギー性結膜炎、眼痛、その他

■ 英語タイトル：Inflammatory Eye Diseases Treatment Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8810）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8810
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：125
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[炎症性眼疾患治療のグローバル市場展望 2023年-2029年：ドライアイ疾患、非感染性前ブドウ膜炎、アレルギー性結膜炎、眼痛、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の炎症性眼疾患治療市場規模と予測を収録しています。・世界の炎症性眼疾患治療市場：売上、2018年-2023年、2024年-2029年
・世界の炎症性眼疾患治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の炎症性眼疾患治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ドライアイ疾患」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

炎症性眼疾患治療のグローバル主要企業は、Allergan、 Alcon、 Novartis、 Bausch & Lomb、 Santen Pharmaceutical、 Johnson & Johnson、 Thea pharmaceuticals、 URSAPHARM、 SIMILASAN、 AbbVie、 OKYO、 Akorn、 United Laboratories、 Sun Pharmaceutical、 Jianfeng Group、 Eyegate Pharmaceuticals、 Regeneron Pharmaceuticals、 Eyepoint pharmaceuticals、 Alimera Sciences、 PanOptica、 Oculis、 Restasisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、炎症性眼疾患治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の炎症性眼疾患治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の炎症性眼疾患治療市場：タイプ別市場シェア、2022年
・ドライアイ疾患、非感染性前ブドウ膜炎、アレルギー性結膜炎、眼痛、その他

世界の炎症性眼疾患治療市場：用途別、2018年-2023年、2024年-2029年
世界の炎症性眼疾患治療市場：用途別市場シェア、2022年
・副腎皮質ホルモン剤、免疫抑制剤、その他

世界の炎症性眼疾患治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の炎症性眼疾患治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における炎症性眼疾患治療のグローバル売上、2018年-2023年
・主要企業における炎症性眼疾患治療のグローバル売上シェア、2022年
・主要企業における炎症性眼疾患治療のグローバル販売量、2018年-2023年
・主要企業における炎症性眼疾患治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Allergan、 Alcon、 Novartis、 Bausch & Lomb、 Santen Pharmaceutical、 Johnson & Johnson、 Thea pharmaceuticals、 URSAPHARM、 SIMILASAN、 AbbVie、 OKYO、 Akorn、 United Laboratories、 Sun Pharmaceutical、 Jianfeng Group、 Eyegate Pharmaceuticals、 Regeneron Pharmaceuticals、 Eyepoint pharmaceuticals、 Alimera Sciences、 PanOptica、 Oculis、 Restasis

*************************************************************

・調査・分析レポートの概要
炎症性眼疾患治療市場の定義
市場セグメント
世界の炎症性眼疾患治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の炎症性眼疾患治療市場規模
世界の炎症性眼疾患治療市場規模：2022年 VS 2029年
世界の炎症性眼疾患治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの炎症性眼疾患治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の炎症性眼疾患治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ドライアイ疾患、非感染性前ブドウ膜炎、アレルギー性結膜炎、眼痛、その他
炎症性眼疾患治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：副腎皮質ホルモン剤、免疫抑制剤、その他
炎症性眼疾患治療の用途別グローバル売上・予測

・地域別市場分析
地域別炎症性眼疾患治療市場規模 2022年と2029年
地域別炎症性眼疾患治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Allergan、 Alcon、 Novartis、 Bausch & Lomb、 Santen Pharmaceutical、 Johnson & Johnson、 Thea pharmaceuticals、 URSAPHARM、 SIMILASAN、 AbbVie、 OKYO、 Akorn、 United Laboratories、 Sun Pharmaceutical、 Jianfeng Group、 Eyegate Pharmaceuticals、 Regeneron Pharmaceuticals、 Eyepoint pharmaceuticals、 Alimera Sciences、 PanOptica、 Oculis、 Restasis
...

Eye inflammation, also referred to as ocular inflammation, is a condition characterized by the swelling of one or more parts of the eyes and is caused by a variety of factors that range from simple irritation to certain diseases.
This report aims to provide a comprehensive presentation of the global market for Inflammatory Eye Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Eye Diseases Treatment. This report contains market size and forecasts of Inflammatory Eye Diseases Treatment in global, including the following market information:
Global Inflammatory Eye Diseases Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Inflammatory Eye Diseases Treatment Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Inflammatory Eye Diseases Treatment companies in 2022 (%)
The global Inflammatory Eye Diseases Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Dry Eye Diseases Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inflammatory Eye Diseases Treatment include Allergan, Alcon, Novartis, Bausch & Lomb, Santen Pharmaceutical, Johnson & Johnson, Thea pharmaceuticals, URSAPHARM and SIMILASAN, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inflammatory Eye Diseases Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inflammatory Eye Diseases Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Inflammatory Eye Diseases Treatment Market Segment Percentages, by Type, 2022 (%)
Dry Eye Diseases
Non-infectious Anterior Uveitis
Allergic Conjunctivitis
Ocular Pain
Other
Global Inflammatory Eye Diseases Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Inflammatory Eye Diseases Treatment Market Segment Percentages, by Application, 2022 (%)
Corticosteroid Drug
Immunosuppressant Drug
Others
Global Inflammatory Eye Diseases Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Inflammatory Eye Diseases Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inflammatory Eye Diseases Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inflammatory Eye Diseases Treatment revenues share in global market, 2022 (%)
Key companies Inflammatory Eye Diseases Treatment sales in global market, 2018-2023 (Estimated), (Units)
Key companies Inflammatory Eye Diseases Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Alcon
Novartis
Bausch & Lomb
Santen Pharmaceutical
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
AbbVie
OKYO
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Eyegate Pharmaceuticals
Regeneron Pharmaceuticals
Eyepoint pharmaceuticals
Alimera Sciences
PanOptica
Oculis
Restasis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inflammatory Eye Diseases Treatment, market overview.
Chapter 2: Global Inflammatory Eye Diseases Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Inflammatory Eye Diseases Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inflammatory Eye Diseases Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inflammatory Eye Diseases Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Inflammatory Eye Diseases Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inflammatory Eye Diseases Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inflammatory Eye Diseases Treatment Overall Market Size
2.1 Global Inflammatory Eye Diseases Treatment Market Size: 2022 VS 2029
2.2 Global Inflammatory Eye Diseases Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Inflammatory Eye Diseases Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Inflammatory Eye Diseases Treatment Players in Global Market
3.2 Top Global Inflammatory Eye Diseases Treatment Companies Ranked by Revenue
3.3 Global Inflammatory Eye Diseases Treatment Revenue by Companies
3.4 Global Inflammatory Eye Diseases Treatment Sales by Companies
3.5 Global Inflammatory Eye Diseases Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inflammatory Eye Diseases Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inflammatory Eye Diseases Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inflammatory Eye Diseases Treatment Players in Global Market
3.8.1 List of Global Tier 1 Inflammatory Eye Diseases Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Inflammatory Eye Diseases Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Inflammatory Eye Diseases Treatment Market Size Markets, 2022 & 2029
4.1.2 Dry Eye Diseases
4.1.3 Non-infectious Anterior Uveitis
4.1.4 Allergic Conjunctivitis
4.1.5 Ocular Pain
4.1.6 Other
4.2 By Type – Global Inflammatory Eye Diseases Treatment Revenue & Forecasts
4.2.1 By Type – Global Inflammatory Eye Diseases Treatment Revenue, 2018-2023
4.2.2 By Type – Global Inflammatory Eye Diseases Treatment Revenue, 2024-2029
4.2.3 By Type – Global Inflammatory Eye Diseases Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Inflammatory Eye Diseases Treatment Sales & Forecasts
4.3.1 By Type – Global Inflammatory Eye Diseases Treatment Sales, 2018-2023
4.3.2 By Type – Global Inflammatory Eye Diseases Treatment Sales, 2024-2029
4.3.3 By Type – Global Inflammatory Eye Diseases Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Inflammatory Eye Diseases Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Inflammatory Eye Diseases Treatment Market Size, 2022 & 2029
5.1.2 Corticosteroid Drug
5.1.3 Immunosuppressant Drug
5.1.4 Others
5.2 By Application – Global Inflammatory Eye Diseases Treatment Revenue & Forecasts
5.2.1 By Application – Global Inflammatory Eye Diseases Treatment Revenue, 2018-2023
5.2.2 By Application – Global Inflammatory Eye Diseases Treatment Revenue, 2024-2029
5.2.3 By Application – Global Inflammatory Eye Diseases Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Inflammatory Eye Diseases Treatment Sales & Forecasts
5.3.1 By Application – Global Inflammatory Eye Diseases Treatment Sales, 2018-2023
5.3.2 By Application – Global Inflammatory Eye Diseases Treatment Sales, 2024-2029
5.3.3 By Application – Global Inflammatory Eye Diseases Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Inflammatory Eye Diseases Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Inflammatory Eye Diseases Treatment Market Size, 2022 & 2029
6.2 By Region – Global Inflammatory Eye Diseases Treatment Revenue & Forecasts
6.2.1 By Region – Global Inflammatory Eye Diseases Treatment Revenue, 2018-2023
6.2.2 By Region – Global Inflammatory Eye Diseases Treatment Revenue, 2024-2029
6.2.3 By Region – Global Inflammatory Eye Diseases Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Inflammatory Eye Diseases Treatment Sales & Forecasts
6.3.1 By Region – Global Inflammatory Eye Diseases Treatment Sales, 2018-2023
6.3.2 By Region – Global Inflammatory Eye Diseases Treatment Sales, 2024-2029
6.3.3 By Region – Global Inflammatory Eye Diseases Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Inflammatory Eye Diseases Treatment Revenue, 2018-2029
6.4.2 By Country – North America Inflammatory Eye Diseases Treatment Sales, 2018-2029
6.4.3 US Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.4.4 Canada Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.4.5 Mexico Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Inflammatory Eye Diseases Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Inflammatory Eye Diseases Treatment Sales, 2018-2029
6.5.3 Germany Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.5.4 France Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.5.5 U.K. Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.5.6 Italy Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.5.7 Russia Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.5.9 Benelux Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Inflammatory Eye Diseases Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Inflammatory Eye Diseases Treatment Sales, 2018-2029
6.6.3 China Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.6.4 Japan Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.6.5 South Korea Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.6.7 India Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Inflammatory Eye Diseases Treatment Revenue, 2018-2029
6.7.2 By Country – South America Inflammatory Eye Diseases Treatment Sales, 2018-2029
6.7.3 Brazil Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.7.4 Argentina Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Inflammatory Eye Diseases Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Inflammatory Eye Diseases Treatment Sales, 2018-2029
6.8.3 Turkey Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.8.4 Israel Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Inflammatory Eye Diseases Treatment Market Size, 2018-2029
6.8.6 UAE Inflammatory Eye Diseases Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Inflammatory Eye Diseases Treatment Major Product Offerings
7.1.4 Allergan Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Alcon
7.2.1 Alcon Company Summary
7.2.2 Alcon Business Overview
7.2.3 Alcon Inflammatory Eye Diseases Treatment Major Product Offerings
7.2.4 Alcon Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Alcon Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Inflammatory Eye Diseases Treatment Major Product Offerings
7.3.4 Novartis Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Bausch & Lomb
7.4.1 Bausch & Lomb Company Summary
7.4.2 Bausch & Lomb Business Overview
7.4.3 Bausch & Lomb Inflammatory Eye Diseases Treatment Major Product Offerings
7.4.4 Bausch & Lomb Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Bausch & Lomb Key News & Latest Developments
7.5 Santen Pharmaceutical
7.5.1 Santen Pharmaceutical Company Summary
7.5.2 Santen Pharmaceutical Business Overview
7.5.3 Santen Pharmaceutical Inflammatory Eye Diseases Treatment Major Product Offerings
7.5.4 Santen Pharmaceutical Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Santen Pharmaceutical Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Inflammatory Eye Diseases Treatment Major Product Offerings
7.6.4 Johnson & Johnson Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Thea pharmaceuticals
7.7.1 Thea pharmaceuticals Company Summary
7.7.2 Thea pharmaceuticals Business Overview
7.7.3 Thea pharmaceuticals Inflammatory Eye Diseases Treatment Major Product Offerings
7.7.4 Thea pharmaceuticals Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Thea pharmaceuticals Key News & Latest Developments
7.8 URSAPHARM
7.8.1 URSAPHARM Company Summary
7.8.2 URSAPHARM Business Overview
7.8.3 URSAPHARM Inflammatory Eye Diseases Treatment Major Product Offerings
7.8.4 URSAPHARM Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.8.5 URSAPHARM Key News & Latest Developments
7.9 SIMILASAN
7.9.1 SIMILASAN Company Summary
7.9.2 SIMILASAN Business Overview
7.9.3 SIMILASAN Inflammatory Eye Diseases Treatment Major Product Offerings
7.9.4 SIMILASAN Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.9.5 SIMILASAN Key News & Latest Developments
7.10 AbbVie
7.10.1 AbbVie Company Summary
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Inflammatory Eye Diseases Treatment Major Product Offerings
7.10.4 AbbVie Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.10.5 AbbVie Key News & Latest Developments
7.11 OKYO
7.11.1 OKYO Company Summary
7.11.2 OKYO Inflammatory Eye Diseases Treatment Business Overview
7.11.3 OKYO Inflammatory Eye Diseases Treatment Major Product Offerings
7.11.4 OKYO Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.11.5 OKYO Key News & Latest Developments
7.12 Akorn
7.12.1 Akorn Company Summary
7.12.2 Akorn Inflammatory Eye Diseases Treatment Business Overview
7.12.3 Akorn Inflammatory Eye Diseases Treatment Major Product Offerings
7.12.4 Akorn Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.12.5 Akorn Key News & Latest Developments
7.13 United Laboratories
7.13.1 United Laboratories Company Summary
7.13.2 United Laboratories Inflammatory Eye Diseases Treatment Business Overview
7.13.3 United Laboratories Inflammatory Eye Diseases Treatment Major Product Offerings
7.13.4 United Laboratories Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.13.5 United Laboratories Key News & Latest Developments
7.14 Sun Pharmaceutical
7.14.1 Sun Pharmaceutical Company Summary
7.14.2 Sun Pharmaceutical Business Overview
7.14.3 Sun Pharmaceutical Inflammatory Eye Diseases Treatment Major Product Offerings
7.14.4 Sun Pharmaceutical Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.14.5 Sun Pharmaceutical Key News & Latest Developments
7.15 Jianfeng Group
7.15.1 Jianfeng Group Company Summary
7.15.2 Jianfeng Group Business Overview
7.15.3 Jianfeng Group Inflammatory Eye Diseases Treatment Major Product Offerings
7.15.4 Jianfeng Group Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.15.5 Jianfeng Group Key News & Latest Developments
7.16 Eyegate Pharmaceuticals
7.16.1 Eyegate Pharmaceuticals Company Summary
7.16.2 Eyegate Pharmaceuticals Business Overview
7.16.3 Eyegate Pharmaceuticals Inflammatory Eye Diseases Treatment Major Product Offerings
7.16.4 Eyegate Pharmaceuticals Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.16.5 Eyegate Pharmaceuticals Key News & Latest Developments
7.17 Regeneron Pharmaceuticals
7.17.1 Regeneron Pharmaceuticals Company Summary
7.17.2 Regeneron Pharmaceuticals Business Overview
7.17.3 Regeneron Pharmaceuticals Inflammatory Eye Diseases Treatment Major Product Offerings
7.17.4 Regeneron Pharmaceuticals Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.17.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.18 Eyepoint pharmaceuticals
7.18.1 Eyepoint pharmaceuticals Company Summary
7.18.2 Eyepoint pharmaceuticals Business Overview
7.18.3 Eyepoint pharmaceuticals Inflammatory Eye Diseases Treatment Major Product Offerings
7.18.4 Eyepoint pharmaceuticals Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.18.5 Eyepoint pharmaceuticals Key News & Latest Developments
7.19 Alimera Sciences
7.19.1 Alimera Sciences Company Summary
7.19.2 Alimera Sciences Business Overview
7.19.3 Alimera Sciences Inflammatory Eye Diseases Treatment Major Product Offerings
7.19.4 Alimera Sciences Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.19.5 Alimera Sciences Key News & Latest Developments
7.20 PanOptica
7.20.1 PanOptica Company Summary
7.20.2 PanOptica Business Overview
7.20.3 PanOptica Inflammatory Eye Diseases Treatment Major Product Offerings
7.20.4 PanOptica Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.20.5 PanOptica Key News & Latest Developments
7.21 Oculis
7.21.1 Oculis Company Summary
7.21.2 Oculis Business Overview
7.21.3 Oculis Inflammatory Eye Diseases Treatment Major Product Offerings
7.21.4 Oculis Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.21.5 Oculis Key News & Latest Developments
7.22 Restasis
7.22.1 Restasis Company Summary
7.22.2 Restasis Business Overview
7.22.3 Restasis Inflammatory Eye Diseases Treatment Major Product Offerings
7.22.4 Restasis Inflammatory Eye Diseases Treatment Sales and Revenue in Global (2018-2023)
7.22.5 Restasis Key News & Latest Developments
8 Global Inflammatory Eye Diseases Treatment Production Capacity, Analysis
8.1 Global Inflammatory Eye Diseases Treatment Production Capacity, 2018-2029
8.2 Inflammatory Eye Diseases Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Inflammatory Eye Diseases Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inflammatory Eye Diseases Treatment Supply Chain Analysis
10.1 Inflammatory Eye Diseases Treatment Industry Value Chain
10.2 Inflammatory Eye Diseases Treatment Upstream Market
10.3 Inflammatory Eye Diseases Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inflammatory Eye Diseases Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 好酸球性喘息治療薬のグローバル市場展望 2023年-2029年：点滴静注型、皮下注射型
  • 各種肝硬変治療サービスのグローバル市場展望 2023年-2029年：手術治療、内科治療
  • アルパース病治療のグローバル市場展望 2023年-2029年：言語療法、理学療法、その他
  • 片頭痛予防治療のグローバル市場展望 2023年-2029年：カルシウムチャネル遮断薬、抗てんかん薬、β遮断薬、カルシウムチャネル調節薬、抗うつ薬、その他
  • 発作性夜間ヘモグロビン尿症（PNH）用治療のグローバル市場展望 2023年-2029年：モノクローナル抗体治療、免疫抑制剤、造血幹細胞移植
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8810 )"炎症性眼疾患治療のグローバル市場展望 2023年-2029年：ドライアイ疾患、非感染性前ブドウ膜炎、アレルギー性結膜炎、眼痛、その他" (英文：Inflammatory Eye Diseases Treatment Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。